I-mIBG: Simplicity and Reproducibility

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2018 Jan 31

PMID 29380284

Authors

Kevin Curl

Christopher L Hansen

Affiliations

Soon will be listed here.

References

Chen W, Cao Q, Dilsizian V . Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections. Curr Cardiol Rep. 2011; 13(2):132-7. DOI: 10.1007/s11886-010-0157-y. View

Henderson E, Kahn J, Corbett J, Jansen D, Pippin J, Kulkarni P . Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation. 1988; 78(5 Pt 1):1192-9. DOI: 10.1161/01.cir.78.5.1192. View

Wieland D, Wu J, Brown L, Mangner T, Swanson D, BEIERWALTES W . Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med. 1980; 21(4):349-53. View

Schofer J, Spielmann R, Schuchert A, Weber K, Schluter M . Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1988; 12(5):1252-8. DOI: 10.1016/0735-1097(88)92608-3. View

Kline R, Swanson D, Wieland D, Thrall J, Gross M, Pitt B . Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med. 1981; 22(2):129-32. View

White C . Catecholamines and their blockade in congestive heart failure. Am J Health Syst Pharm. 1998; 55(7):676-82. DOI: 10.1093/ajhp/55.7.676. View

Travin M . Cardiac autonomic imaging with SPECT tracers. J Nucl Cardiol. 2012; 20(1):128-43. DOI: 10.1007/s12350-012-9655-1. View

Kamiyoshi Y, Yazaki Y, Urushibata K, Koizumu T, Kasai H, Izawa A . Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2008; 101(10):1482-6. DOI: 10.1016/j.amjcard.2008.01.030. View

Jacobson A, Senior R, Cerqueira M, Wong N, Thomas G, Lopez V . Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010; 55(20):2212-21. DOI: 10.1016/j.jacc.2010.01.014. View

10.

Veltman C, Boogers M, Meinardi J, Al Younis I, Dibbets-Schneider P, van der Wall E . Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging. 2012; 39(10):1599-608. PMC: 3458210. DOI: 10.1007/s00259-012-2180-2. View

11.

Kaul S, Finkelstein D, Homma S, Leavitt M, Okada R, Boucher C . Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol. 1988; 12(1):25-34. DOI: 10.1016/0735-1097(88)90351-8. View

12.

. Guidelines for clinical use of cardiac nuclear medicine (JCS 2010) – digest version – . Circ J. 2012; 76(3):761-7. DOI: 10.1253/circj.cj-88-0019. View

13.

Gerson M, Dwivedi A, Abdallah M, Shukla R, Jacobson A . Significance of I-123 metaiodobenzylguanidine (¹²³I-MIBG) lung activity in subjects with heart failure in comparison to healthy control subjects. J Nucl Cardiol. 2013; 20(4):592-9. DOI: 10.1007/s12350-013-9714-2. View

14.

Kasama S, Toyama T, Hatori T, Sumino H, Kumakura H, Takayama Y . Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol. Eur Heart J. 2007; 28(8):989-95. DOI: 10.1093/eurheartj/ehm048. View

15.

Agostini D, Carrio I, Verberne H . How to use myocardial 123I-MIBG scintigraphy in chronic heart failure. Eur J Nucl Med Mol Imaging. 2008; 36(4):555-9. DOI: 10.1007/s00259-008-0976-x. View

16.

Kasama S, Toyama T, Sumino H, Matsumoto N, Sato Y, Kumakura H . Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. J Nucl Med. 2007; 48(12):1993-2000. DOI: 10.2967/jnumed.107.045427. View

17.

Gill J, Hunter G, Gane G, Camm A . Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J. 1993; 126(2):390-8. DOI: 10.1016/0002-8703(93)91056-k. View

18.

Gould P, Kong G, Kalff V, Duffy S, Taylor A, Kelly M . Improvement in cardiac adrenergic function post biventricular pacing for heart failure. Europace. 2007; 9(9):751-6. DOI: 10.1093/europace/eum081. View

19.

Kopin I . False adrenergic transmitters. Annu Rev Pharmacol. 1968; 8:377-94. DOI: 10.1146/annurev.pa.08.040168.002113. View

20.

Narula J, Gerson M, Thomas G, Cerqueira M, Jacobson A . ¹²³I-MIBG Imaging for Prediction of Mortality and Potentially Fatal Events in Heart Failure: The ADMIRE-HFX Study. J Nucl Med. 2015; 56(7):1011-8. DOI: 10.2967/jnumed.115.156406. View